Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
40 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

SBFM — Sunshine Biopharma, Inc. Dilution Risk Tracker

Track SBFM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SBFM — Get alerts when the score changes →

As of August 28, 2026, Sunshine Biopharma, Inc. (SBFM) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Sunshine Biopharma, Inc. has a market capitalization of $410.8K, 3.88M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $4.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊Float Risk
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 32%
🔄 Reverse Split model est. 55%
• 50-day avg $0.88 below $1 exchange minimum
💰 Capital Raise model 18%
• Active ATM program with $4M remaining capacity
🔔 Track SBFM — Get forecast alerts →

Market Data

Market Cap$410.8K
Shares Outstanding3.88M
FloatN/A
Cash$19.73M
Debt$2.05M
Short InterestN/A

Institutional Holdings

10 institutional holders · 122.2K shares
#1 Citadel Advisors Llc 46.2K shares
#2 Two Sigma Securities, LLC 23.5K shares
#3 Xtx Topco Ltd 21.5K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest126.4K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2025-12-31
SC 13G/A BENEFICIAL OWNERSHIP 2026-08-14
SC 13G/A BENEFICIAL OWNERSHIP 2026-08-13
4 INSIDER TRANSACTION 2026-08-11
Full SEC filing analysis available with free account

Recent News

Factual SBFM Dilution Snapshot

Sunshine Biopharma, Inc. (SBFM) has a DilutionScore of 40/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track SBFM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SBFM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for SBFM
SBFM FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.